The Pennant Group, Inc. (PNTG)
USD 28.15
(-3.63%)
USD 28.15
(-3.63%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 544.89 Million USD | 15.14% |
| 2022 | 473.24 Million USD | 7.63% |
| 2021 | 439.69 Million USD | 12.47% |
| 2020 | 390.95 Million USD | 15.49% |
| 2019 | 338.53 Million USD | 18.34% |
| 2018 | 286.05 Million USD | 13.97% |
| 2017 | 250.99 Million USD | 15.54% |
| 2016 | 217.22 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 168.74 Million USD | 7.54% |
| 2024 Q1 | 156.91 Million USD | 7.51% |
| 2023 Q1 | 126.46 Million USD | 1.44% |
| 2023 FY | 544.89 Million USD | 15.14% |
| 2023 Q2 | 132.28 Million USD | 4.6% |
| 2023 Q3 | 140.19 Million USD | 5.98% |
| 2023 Q4 | 145.95 Million USD | 4.11% |
| 2022 Q4 | 124.66 Million USD | 5.34% |
| 2022 FY | 473.24 Million USD | 7.63% |
| 2022 Q3 | 118.35 Million USD | 1.75% |
| 2022 Q2 | 116.31 Million USD | 2.11% |
| 2022 Q1 | 113.91 Million USD | 1.92% |
| 2021 Q2 | 110.34 Million USD | 4.43% |
| 2021 Q1 | 105.66 Million USD | -2.13% |
| 2021 FY | 439.69 Million USD | 12.47% |
| 2021 Q3 | 111.92 Million USD | 1.43% |
| 2021 Q4 | 111.76 Million USD | -0.14% |
| 2020 Q2 | 92.74 Million USD | 0.97% |
| 2020 FY | 390.95 Million USD | 15.49% |
| 2020 Q4 | 107.96 Million USD | 9.73% |
| 2020 Q3 | 98.39 Million USD | 6.1% |
| 2020 Q1 | 91.84 Million USD | 2.63% |
| 2019 Q2 | 82.73 Million USD | 6.2% |
| 2019 FY | 338.53 Million USD | 18.34% |
| 2019 Q3 | 88.39 Million USD | 6.85% |
| 2019 Q1 | 77.9 Million USD | 3.41% |
| 2019 Q4 | 89.49 Million USD | 1.24% |
| 2018 Q2 | 69.78 Million USD | 2.66% |
| 2018 Q3 | 72.95 Million USD | 4.53% |
| 2018 FY | 286.05 Million USD | 13.97% |
| 2018 Q1 | 67.97 Million USD | 0.0% |
| 2018 Q4 | 75.33 Million USD | 3.27% |
| 2017 FY | 250.99 Million USD | 15.54% |
| 2016 FY | 217.22 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 81.395% |
| Addus HomeCare Corporation | 1.05 Billion USD | 48.53% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -178.123% |
| Amedisys, Inc. | 2.23 Billion USD | 75.635% |
| American Oncology Network, Inc. | 1.27 Billion USD | 57.403% |
| Astrana Health, Inc. | 1.38 Billion USD | 60.705% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 71.249% |
| IMAC Holdings, Inc. | 5.19 Million USD | -10384.722% |
| biote Corp. | 185.36 Million USD | -193.964% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -1638.439% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 73.022% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | 12.718% |
| The Ensign Group, Inc. | 3.72 Billion USD | 85.389% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 67.399% |
| InnovAge Holding Corp. | 763.85 Million USD | 28.666% |
| Assure Holdings Corp. | 255 Thousand USD | -213582.745% |
| The Joint Corp. | 117.69 Million USD | -362.963% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 48.384% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -5160.319% |
| ModivCare Inc. | 2.75 Billion USD | 80.194% |
| NewGenIvf Group Limited | 5.13 Million USD | -10508.932% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -4234.157% |
| Option Care Health, Inc. | 4.3 Billion USD | 87.335% |
| P3 Health Partners Inc. | 1.26 Billion USD | 56.972% |
| P3 Health Partners Inc. | 1.26 Billion USD | 56.972% |
| Surgery Partners, Inc. | 2.74 Billion USD | 80.137% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -9779.905% |
| Talkspace, Inc. | 150.04 Million USD | -263.152% |
| Talkspace, Inc. | 150.04 Million USD | -263.152% |
| The Oncology Institute, Inc. | 324.23 Million USD | -68.052% |
| The Oncology Institute, Inc. | 324.23 Million USD | -68.052% |